Advertisement

Topics

Latest "Xoma Novartis Partner Beta MAbs Related" News Stories

08:06 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Xoma Novartis Partner Beta MAbs Related" found in our extensive news archives from over 250 global news sources.

More Information about Xoma Novartis Partner Beta MAbs Related on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Xoma Novartis Partner Beta MAbs Related for you to read. Along with our medical data and news we also list Xoma Novartis Partner Beta MAbs Related Clinical Trials, which are updated daily. BioPortfolio also has a large database of Xoma Novartis Partner Beta MAbs Related Companies for you to search.

Showing "Xoma Novartis Partner Beta MAbs Related" News Articles 1–25 of 14,000+

Tuesday 18th December 2018

Notal Vision selects Wasatch to bring AI-enabled SD-OCT system closer to market

The first targeted application of the Notal Home OCT is to monitor exudative (wet) age-related macular degeneration (eAMD) patients between scheduled, standard-of-care examinations by their treating retinal specialist. The post Notal Vision selects Wasatch to bring AI-enabled SD-OCT system closer to market appeared first on Compelo Medical Devices.


Cybeats Announces $3M Investment for Cybersecurity and Lifecycle Management for IoT Devices

Cybersecurity protection solution provides software-based microagent for smart buildings, medical devices, and critical infrastructure Cybeats, a rapidly growing cybersecurity company protecting Internet of Things (IoT) devices, today announced it has raised $3 million to expand the team in Toronto and abroad. The round was led by early...

Semma Therapeutics Expands Executive Leadership Team

-- Appoints David Lebwohl, M.D., as Chief Medical Officer, David DiGiusto, Ph.D., as Chief Technology Officer and Ann Darda as Head of Human Resources -- Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced the appointments of David Lebwohl, M.D., as Chief Medical Officer ...


AstraZeneca partner gets approval to market its roxadustat drug as an anaemia treatment in China

The FTSE 100-listed drugmaker said its partner FibroGen China received marketing authorisation from the Chinese National Medical Products Administration for orally-administered roxadustat

Elanco Announces 2019 Financial Guidance

2019 revenue is expected to be between $3.10 billion and $3.16 billion. Earnings per share (EPS) for 2019 are expected to be in the range of $0.36 to $0.48 on a reported basis and $1.02 to $1.12 on an adjusted basis. The company now expects 2018 EPS to be in the range of $0.15 to $0.17 on a reported bas...

Hitachi Chemical Co Ltd 4217 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryHitachi Chemical Co Ltd Hitachi Chemical, a subsidiary of Hitachi Ltd, is a chemical manufacturer. It carries out the manufacture and sale of advanced components and systems such as energy storage devices and systems, and electronic components. The company's product portfolio includes electronics materials, inorganic materials, polymer science materials, semiconductor and display related ma...

TransGenic Inc 2342 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryTransGenic Inc TransGenic is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The products and services of the company include knockout mouse and phenotype database, genetically engineered mice, custom production of knock out mouse, custom production of antibodies and proteins, drug discovery and support ...

Notal Vision works with Wasatch Photonics to develop AI-enabled home-based optical coherence tomography

The first targeted application of the Notal Home OCT is to monitor exudative (wet) age-related macular degeneration (eAMD) patients between scheduled, standard-of-care examinations by their treating retinal specialist. The post Notal Vision works with Wasatch Photonics to develop AI-enabled home-based optical coherence tomography appeared first on Compelo Medical Devices.

Australia Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and Others [Report Updated: 19102018] Prices from USD $5096

Australia Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and OthersSummaryGlobalData's new report, Australia Anesthesia and Respiratory Devices Market Outlook to 2025, provides key market data on the Australia Anesthesia and Respiratory Devices market. The report provides value, in millions of US dollars, volume in...

PredictImmune Makes Further Strides Towards January Launch of PredictSURE IBD™, by Gaining ISO 13485 Medical Devices Certification

Certification demonstrates PredictImmune’s on-going commitment to the provision of high-quality processes to support the development of its in-vitro diagnostic pipeline PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced confirmation of its ...

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and Others [Report Updated: 19102018] Prices from USD $5096

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and OthersSummaryGlobalData's new report, United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2025, provides key market data on the United Kingdom Anesthesia and Respiratory Devices market. The report provides value, in millions of US dol...

Researchers at Oxford Brookes University use the ZetaView® from Analytik Partner, Particle Metrix, to Study Extracellular Vesicles.

Analytik, leading suppliers of innovative analytical instrumentation, report on their Particle Metrix ZetaView® users at Oxford Brookes University who are studying extracellular vesicles. Dr Genevieve Melling is a postdoctoral researcher in the Department of Biological and Medical Sciences at Oxford Brookes University. She works in the laboratory of Dr Dave Carter which has been established to...

One-carbon Metabolic Pathway Implicated In Age-Related Immunosenescence

Aspen And Mylan Strike A Deal On Australia And New Zealand Portfolio

Mylan has bolstered its presence in key Australasian markets through a portfolio distribution arrangement with Aspen Pharma, which includes an...   

STAT Plus: @Novartis is trying to prepare payers and policymakers for a forthcoming gene therapy that the company argues would be cost effective at $4 million to $5 million for each patient. https://buff.ly/2QyTROx 

STAT Plus: @Novartis is trying to prepare payers and policymakers for a forthcoming gene therapy that the company argues would be cost effective at $4 million to $5 million for each patient. https://buff.ly/2QyTROx 

Monday 17th December 2018

BRIC Crown and Bridge Materials Market Outlook to 2025 [Report Updated: 01102018] Prices from USD $5096

BRIC Crown and Bridge Materials Market Outlook to 2025SummaryGlobalData's new report, BRIC Crown and Bridge Materials Market Outlook to 2025, provides key market data on the BRIC Crown and Bridge Materials market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Permanent Bridges and Permanent Crowns.The report also provides compa...

EU5 Crown and Bridge Materials Market Outlook to 2025 [Report Updated: 01102018] Prices from USD $5096

EU5 Crown and Bridge Materials Market Outlook to 2025SummaryGlobalData's new report, EU5 Crown and Bridge Materials Market Outlook to 2025, provides key market data on the EU5 Crown and Bridge Materials market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Permanent Bridges and Permanent Crowns.The report also provides company ...

New battery-free, implantable device aids weight loss

More than 700 million adults and children worldwide are obese, according to a 2017 study that called the growing number and weight-related health problems a "rising pandemic."

SHAREHOLDER ALERT: Monteverde Associates PC Announces An Investigation Of SendGrid, Inc. - SEND

NEW YORK, Dec. 17, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Read more...

SHAREHOLDER ALERT: Monteverde Associates PC Announces An Investigation Of Owens Realty ...

NEW YORK, Dec. 17, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Read more...

SHAREHOLDER ALERT: Monteverde Associates PC Announces An Investigation Of L3 Technologies, Inc. ...

NEW YORK, Dec. 17, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Read more...

Celltrion’s Global Ambitions On Track As Third Biosimilar Approved In US

With the US approval of its third biosimilar product, Herzuma, Korean group Celltrion appears to be on a continued growth...    

Sandoz and Ares Genetics partner to develop anti-infectives platform

Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to support drug development and life...Read More... The post Sandoz and Ares Genetics partner to develop anti-infectives platform appeared first on Pharmaceutical Technology.

Vitiligo Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Vitiligo Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Vitiligo Global Clinical Trials Review, H2, 2018" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. T...

Pharma May See Brighter Enforcement Environment After US Justice Department Policy Changes

Policy revisions on individual liability for corporate misconduct, noncompliance with agency guidance documents and dismissal of False Claims Act cases...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks